Clinical Trial Update: Effect of Saccharomyces Boulardii on Indirect Hyperbilirubinemia and Phototherapy Duration in Very Low Birth Weight Infants [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether Saccharomyces boulardii reduces indirect hyperbilirubinemia-related phototherapy duration in very low birth weight i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indirect Hyperbilirubinemia

Drugs mentioned

• Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Indirect Hyperbilirubinemia | Phase 4 | Status: UNKNOWN